Tuberculosis preventive therapy – Clinical practice issues

Author:

Ghoshal Aloke Gopal1,Sarkar Supriya2,Halder Arup Kumar3,Dhua Aparup4,Das Chandra Sekhar5,Das Parthajit6,Chowdhury Abhra Chandra7,Thakur Sanjay Kumar Daulat8,Majumder Anindya Kishore9

Affiliation:

1. Director, National Asthma, Allergy and Bronchitis Institute

2. Professor in Respiratory Medicine, University College of Medicine, Sugared Dutta Medical College & Hospital

3. Consultant Pulmonologist, Calcutta Medical Research Institute

4. Associate Professor in Respiratory Medicine, University College of Medicine, Sugared Dutta Medical College & Hospital, https://orcid.org/0000-0002-5261-2303

5. City Tuberculosis Officer (CTO), Calcutta Municipal corporation

6. Assistant Professor in Rheumatology, Ramkrishna Mission Seva Pratisthan

7. Consultant Rheumatologist, CMRI Hospital

8. Professor & HOD, Ophthalmology Midnapore Medical College & Hospital

9. Consultant Ophthalmic surgeon in Netralayam super speciality Eye Care Hospital, Mukundapur & VIP

Abstract

Latent tuberculosis (LTB) is now termed as tuberculosis infection (TBI). Prevention of active TB disease by treatment of tuberculosis infection is a critical component of the National Strategic Plan 2017-25 for TB Elimination in India by 2025. Programmatic Management of Tuberculosis Preventive Therapy (PMTPT) is a public health document while treatment of tuberculosis infection is essentially a clinical approach. Here we have attempted to address the gray areas answering from clinical viewpoint.

Publisher

Medknow

Reference46 articles.

1. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam;Sloot;Am J Respir Crit Care Med,2014

2. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management [Internet];Organization;World Health Organization;,2018

3. Strategies for ending tuberculosis in the South-East Asian Region: a modelling approach;Arinaminpathy;Indian J Med Res,2019

4. Toward a Safe and Reachable Preventive Therapy for LTBI: a multicenter randomized controlled study in Taiwan;Sun;Tuberculosis,2018

5. New regimens to prevent tuberculosis in adults with HIV infection;Martinson;N Engl J Med,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3